Annexon, Inc. (ANNX) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Annexon reported revenue of $0. Net income was -$206.7M, or -$1.34 per diluted share. Operating activities generated -$186.4M of cash, leaving -$186.5M of free cash flow. At fiscal year end, Annexon held $277.6M in total assets against $65.9M in total liabilities, including $162.1M of cash and equivalents.
Open the full interactive Annexon financials → Quarterly statements, key ratios, valuation history and price charts.
Annexon Key Stats
| Share Price | $3.83 |
|---|---|
| Market Cap | $769.8M |
| 52-Week Range | $2.68 – $6.96 |
| Shares Outstanding | 201.0 million (basic, 2026 Q2) |
Annexon Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$63.5M | -$130.7M | -$145.6M | -$143.7M | -$154.1M | -$216.4M |
| Pre-Tax Income | -$63.4M | -$130.3M | $141.9M | $134.2M | $138.2M | -$206.7M |
| Income Tax | — | — | $283.9M | $0 | $0 | $0 |
| Net Income | -$63.4M | -$130.3M | -$141.9M | -$134.2M | -$138.2M | -$206.7M |
| Diluted EPS | -$4.15 | -$3.40 | -$2.60 | -$1.77 | -$1.01 | -$1.34 |
Annexon Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$54.9M | -$48.3M | -$44.1M | -$55.3M |
| Diluted EPS | -$0.37 | -$0.31 | -$0.23 | -$0.28 |
Annexon Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $268.6M | $74.8M | $140.0M | $225.1M | $49.5M | $162.1M |
| Current Assets | $354.0M | $247.7M | $248.1M | $263.9M | $316.5M | $242.2M |
| Total Assets | $355.9M | $287.0M | $285.1M | $297.7M | $350.1M | $277.6M |
| Current Liabilities | $10.6M | $21.7M | $22.4M | $17.9M | $30.5M | $42.6M |
| Total Liabilities | $11.7M | $55.1M | $53.9M | $47.1M | $57.0M | $65.9M |
| Shareholders' Equity | $344.3M | $231.9M | $231.2M | $250.6M | $293.1M | $211.6M |
Annexon Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$53.1M | -$106.1M | -$116.3M | -$121.1M | -$118.0M | -$186.4M |
| Cash From Investing | -$83.2M | -$88.2M | $58.4M | $70.7M | -$218.8M | $190.1M |
| Cash From Financing | $360.9M | $1.8M | $122.9M | $135.5M | $161.2M | $108.9M |
| Free Cash Flow | -$53.6M | -$107.8M | -$122.8M | -$121.3M | -$118.0M | -$186.5M |
Figures from Annexon's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Annexon financials page for every line item.
Annexon Company Profile
| Ticker | ANNX |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Brisbane, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001528115 |
Frequently Asked Questions
What was Annexon's revenue in fiscal 2025?
Annexon (ANNX) reported revenue of $0 for fiscal 2025.
What is Annexon's annual revenue history?
Annexon's annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Annexon's net income in fiscal 2025?
Annexon reported net income of -$206.7M for fiscal 2025.
What was Annexon's earnings per share (EPS) in fiscal 2025?
Annexon's diluted EPS was -$1.34 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Annexon generate in fiscal 2025?
Annexon generated -$186.5M of free cash flow in fiscal 2025.
What was Annexon's revenue last quarter?
In its most recent reported quarter (2026 Q2), Annexon reported revenue of $0.
How many shares of Annexon are outstanding?
Annexon reported a weighted average of 201.0 million basic shares outstanding in 2026 Q2.
What is Annexon's market cap?
Based on its latest closing price, Annexon (ANNX) has a market capitalization of about $769.8M.
When does Annexon's fiscal year end?
Annexon's fiscal year end, as registered with the SEC, is December 31.
Where is Annexon headquartered?
Annexon lists its business address in Brisbane, California in its SEC filings.